Article Details
Retrieved on: 2025-01-01 23:34:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Innovent Biologics has entered into an exclusive global license agreement with Roche for IBI3009, a novel DLL3-targeted antibody drug conjugate ...
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here